Almost every cell in the human body extends a primary cilium. Defective cilia function leads to a set 16 of disorders known as ciliopathies characterised by debilitating developmental defects affecting 17 many tissues. Here we report a new role for regulator of calcineurin 2, RCAN2, in primary cilia 18 function. It localises to centrioles and the basal body and is required to maintain normal cilia length. 19 RCAN2 was identified as the most strongly upregulated gene from a comparative RNAseq analysis of 20 cells in which expression of the Golgi matrix protein giantin had been abolished by gene editing. In 21 contrast to previous work where we showed that depletion of giantin by RNAi results in defects in 22 ciliogenesis and in cilia length control, giantin knockout cells generate normal cilia on serum 23
Introduction 29
Ciliogenesis, the emergence of a microtubule axoneme from the mother centriole, is fundamental 30 for the ability of non-cycling cells to sense and respond to their environment (Lechtreck, 2015) . 31 Defects in the formation and/or function of the cilium lead to a cohort of human diseases known as 32 ciliopathies (Braun and Hildebrandt, 2016) which affect multiple tissues leading to problems with 33 respiratory, kidney, and heart function as well as vision, hearing, and fertility. Cilia defects are also 34 linked to obesity and diabetes. Movement of cargo and signalling complexes into and out of cilia 35 requires intraflagellar transport (IFT), the process by which microtubule motors drive motility along 36 the axoneme. The ability of cilia to act as confined signalling hubs directing key developmental and 37
homeostatic pathways, such as those linked to sonic hedgehog (Shh) signalling ( We have shown previously using RNAi that the golgin giantin is required for ciliogenesis in vitro 45 (Asante et al., 2013) . This was linked to the accumulation of the dynein-2 motor complex around the 46 ciliary base. Dynein-2 is the major motor driving retrograde IFT along the axoneme and is, among 47 other functions, required for the transduction of the Shh signal (He et al., 2016). Consistent with our 48 findings using RNAi in cultured cells, morpholino knockdown of giantin in zebrafish resulted in fewer 49 but longer cilia in the neural tube (Bergen et al., 2017) . In contrast, recent characterisation of giantin 50 KO zebrafish shows that, while breeding and developing grossly similar to wild-type fish, giantin 51 knockout (KO) fish show a significant decrease in body length (more notable in young adults) and 52 have defects in extracellular matrix, cartilage and bone formation, but only minor cilia defects 53 (Bergen et al., 2017) . 54
We recently generated a KO cell line that no longer expresses giantin (Stevenson et al., 2017) . Here 55 we show that in contrast to depletion of giantin, complete knockout of the gene does not prevent 56 cells from generating cilia on serum withdrawal. We hypothesised that compensatory mechanisms 57 might enable KO cells to produce normal cilia, while acute suppression of expression using RNAi did 58 not allow such compensation. Such mechanisms would also explain the relatively mild manifestation 59 of ciliary defects in giantin mutant zebrafish compared to in vivo morpholino knockdown. RNAseq 60 showed that RCAN2 (Regulator of Calcineurin-2, also called calcipressin-2 and ZAKI-4) is the most 61 strongly upregulated gene in these giantin KO cells. Here we show that RCAN2 localises to centrioles 62 and its depletion affects ciliogenesis. Furthermore, removal of RCAN2 in giantin KO cells 63 recapitulates the giantin RNAi ciliary length phenotype. 64 65
Results and Discussion 66

Giantin KO cells show no gross defects in ciliogenesis 67
Using RNAi, we have shown previously that a reduction in expression of giantin is associated with a 68 ciliogenesis defect in cells (Asante et al., 2013) . Giantin-depleted cells produce fewer cilia and those 69 3 that remain are longer suggesting a defect in length control. In contrast, analysis of giantin knockout 70 RPE-1 cells (Stevenson et al., 2017) shows no gross defects in ciliogenesis at the level of light 71 microscopy ( Fig. 1A , quantified in B) or any significant change in cilia length (Fig. 1A, quantified fully  72 in later experiments). Using serial section transmission electron microscopy, we detect no obvious 73 abnormalities in the structure of the basal body, appendages, or ciliary pocket ( Fig. 1C , enlarged in 74 Cii). Furthermore, Golgi structure appears normal (see (Stevenson et al., 2017) ). This phenotypic 75 discrepancy between knockdown and KO cells is consistent with our observations in zebrafish 76 (Bergen et al., 2017) and led us to hypothesise that altered expression of another gene or genes 77 compensates for loss of giantin. A caveat to these experiments is that we were only able to derive 78 one knockout line for giantin in RPE1 cells. 79
RNAseq of triplicate RNA samples from these and control cells followed by pairwise statistical 80 comparison identified 1025 genes whose expression level is decreased >4-fold. These data are 81 described in Stevenson et al. (2017) and the raw data are available via the ArrayExpress database 82 (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-5618. The most highly upregulated 83 gene, and therefore the most likely to underpin any compensation for loss of giantin, is RCAN2. 84
RCAN2 is a negative regulator of calcineurin and modulates Ca 2+ -dependent signalling. Calcineurin is 85 required for transcriptional signalling; RCAN2 acts as a negative regulator of nuclear factor of 86
activated T-cells (NFAT) activation and therefore of NFAT-dependent transcription. RNAseq showed 87 that in giantin KO cells, RCAN2 is >256x upregulated compared to the parental cell line (Stevenson et  88 al., 2017), implicating RCAN2 in adapting cells to the lack of giantin. 89
To determine whether RCAN2 upregulation is a conserved response to loss of giantin, we examined 90 expression of RCAN2 in two giantin knockout (KO) zebrafish lines (Bergen et al., 2017) . Using cDNA 91 derived from young adult dissected jaw and skull bone and cartilage elements, qPCR expression 92 analyses showed that zebrafish rcan2 is 3.9 and 2.5-fold up-regulated in giantin 93
X3078 and Q2948X mutant lines respectively, when normalised to β-actin (actb1) as control ( Fig. 2A ). 94
Expression levels of hypoxanthine-guanine phosphoribosyl transferase 1 (hprt1) and glyceraldehyde-95 3-phosphate dehydrogenase (gapdh) were not significantly changed. This shows that upregulation of 96 RCAN2 following loss of giantin is conserved and is therefore consistent with the hypothesis that the 97 limited phenotypes seen in both giantin KO models are due to compensation. This also reduces 98 concerns arising from the analysis of only one giantin knockout RPE1 cell line. We postulated that if 99 this dramatic increase in expression is responsible for the limited phenotypes of giantin knockouts, 100 then RCAN2 should have a key role in ciliogenesis. 101
The localisation of RCAN2 has not been reported. Immunofluorescence of RCAN2 in RPE-1 cells 102
showed that it localised to centrioles ( Fig. 2B ) and occasionally showed enhanced localisation to the 103 mother centriole (25% +/-11%, n=3 independent experiments) from which the primary cilium 104 extends (shown by acetylated tubulin labelling in Fig. 2C ). This was confirmed by labelling with the 105 distal appendage protein CEP170 ( Fig. 2D ) which can be used as a marker of the mother centriole 106
(Huang et al., 2017). In those cases where only one centriole is evident from RCAN2 labelling (7% of 107 cells +/-3% n=3 independent experiments), we always see the axoneme extending from, and 108 CEP170 associated with, that centriole. 109
To determine whether RCAN2 was compensating for giantin depletion with respect to cilium length, 110
we depleted RCAN2 using two individual siRNA duplexes ( Fig. 3 ) as well as a pool of 4 duplexes ( Fig.  111 S1). This experiment validated the specificity of the antibody used since centriolar labelling was lost 112 4 following RNAi suppression of RCAN2 expression ( Fig. 3A ). The efficacy of suppression was measured 113 as a function of the intensity of RCAN2 labelling at the centrioles ( Fig 3B) . Unfortunately, the 114 antibody was not found suitable for immunoblotting. Depletion of RCAN2 did not affect the 115 proportion of cells that could generate cilia following serum withdrawal ( Fig. 3C ). Quantification of 116 these data showed that in WT RPE-1 cells, suppression of RCAN2 resulted in shorter cilia ( Fig. 3D ). In 117 contrast, depletion of RCAN2 in giantin KO cells resulted in longer cilia, even when compared to 118 controls. Our hypothesis was that RCAN2 could be suppressing the phenotypes seen following acute 119 loss of giantin in RNAi experiments, namely an increase in cilia length. Consistent with this, we see 120 that reducing the levels of RCAN2 in giantin KO cells recapitulates the longer cilia phenotypes seen 121 on giantin knockdown in WT cells (Asante et al., 2013) . Depletion of RCAN2 has no effect on the 122 integrity of the Golgi, nor on targeting of the glycosyltransferase galactosyltransferase T (GalT) ( Fig.  123 S1B versus S1A). The efficacy of depletion of RCAN2 using a pool of 4 siRNA duplexes is also shown 124 ( Fig. S1D) . It was not possible to study the effects of RCAN2 overexpression in these experiments as 125 transfection with myc-RCAN2 blocked ciliogenesis in >80% of transfected cells. Attempts to titrate 126 expression levels were unsuccessful. 127
Our data strongly suggest that upregulation of RCAN2 ameliorates defects in cilia length control. The 128 phenotypes we observe following acute and partial depletion of giantin in mammalian cells (Asante  129  et whereby increasing RCAN2 levels lead to reducing cilium lengths. In WT cells depleted of RCAN2, cilia 133 are unable to maintain their length and so become shorter, whereas in giantin KO cells the loss of 134 length regulation means the effects of giantin loss become dominant and cilia become longer. 135
It is interesting that our data implicate cilium length control by compensatory pathways in vitro in 136 proliferating cells. The importance of cilia to cell growth in culture is poorly understood and so we 137 cannot predict whether defective ciliogenesis alone would provide sufficient adaptive pressure for 138 RCAN2 upregulation. It is possible however that loss of giantin results in a pro-ciliary phenotype 139 which is compensated by upregulation of RCAN2. In support of this, we find that overexpression of 140 myc-RCAN2 results in far fewer cells (<20%) that produce cilia ( Fig. 4A , n=100 cells) and indeed 141 incidences (~10% of myc-RCAN2-expressing cells) where we can detect Arl13b positive structures 142 that are devoid of acetylated-tubulin labelling ( Fig. 4B ). These are similar in appearance to 143
"decapitated" cilia that have been described by others to drive cilia resorption and cell cycle 144 progression (Phua et al., 2017). In addition, RCAN2 may be acting as a regulator of gene transcription 145 through NFAT signalling to correct other deficiencies in the KO cells. For example, we have shown 146 previously that the glycosyltransferase content of the Golgi apparatus is altered in giantin KO cells 147
suggesting glycosylation defects arising from loss of giantin function might have been corrected to 148 generate bioequivalent glycans (Stevenson et al 2017). 149
Many studies have shown that RCAN2 regulates calcineurin-dependent activation of NFAT signalling 150 and subsequently NFAT-dependent transcriptional programmes. To confirm that upregulation of 151 RCAN2 in giantin KO cells is of functional importance, we examined NFAT localisation in WT and 152 giantin KO cells by immunofluorescence ( Fig. 4C ). As shown in Fig. 4D , the ratio of nuclear vs 153 cytoplasmic levels of NFAT1 was higher in giantin KO cells compared to WT. This nuclear localisation 154 was further enhanced in response to serum starvation. The distribution of NFAT1 in cells depleted of 155 5 giantin by shRNA was similar to that in wild-type cells, supporting our argument that acute giantin 156 depletion does not induce adaptation in these timescales, hence the longer cilia. We would like to thank the Earlham Institute for the RNAseq analysis. We also thank the MRC and 209
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(CGUACGCGGAAUACUUCGAUU) was used as a negative control. All siRNA reagents were prepared in 303 2M CaCl2 and incubated for 5 min at room temperature before an equal volume of 2X BES buffered 304 solution (BBS) was added to the solution and allowed to equilibrate for a further 30 min at room 305 temperature. Final siRNA concentrations used were 5 μM. Confluent RPE-1 cells grown on round 22 306 mm glass coverslips in Costar 6-well plates. Cells were incubated at 37 o C, 3% CO2 for 24 h before 307
replacing the growth media. Cells were grown for an additional 24 h at 37 o C, 5% CO2 then serum 308 starved for ciliogenesis assays. 309
Antibodies, labelling and microscopy 310
Antibodies used: mouse monoclonal anti-giantin (full length, Abcam, Cambridge, UK, ab37266), 311 rabbit polyclonal anti-giantin (N-terminus, Covance, CA, PRB-114C), rabbit anti-RCAN2 (GTX31373,  312 Insight Biotechnology, London UK), anti-Arl13b (17711- (C) RCAN2 is frequently (25% +/-11%, n=3 independent experiments) found concentrated at the mother centriole (from which the cilium extends) as shown by acetylated tubulin labelling of the ciliary axoneme (arrowhead). Where only one puncta of RCAN2 labelling is found (asterisk, (7% of cells +/-3%, n=3 independent experiments)), a ciliary axoneme is always found extending from this centriole. Bar in B = 5 µm. (D) The distal appendage protein CEP170 is found associated with the brighter of the two RCAN2-positive centrioles (arrowhead) as well as with single centrioles positive for CEP170 (asterisk). Boxes are 5 x 5 µm. 
